| Followers | 80 |
| Posts | 5615 |
| Boards Moderated | 0 |
| Alias Born | 11/18/2013 |
Monday, April 17, 2023 9:50:04 AM
What you think now? PM runner based on the float size?
Recent CNSP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 01:03:22 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 05/19/2026 09:02:09 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/19/2026 08:55:38 PM
- CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress • ACCESS Newswire • 05/14/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 11:55:30 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 11:05:18 AM
- CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing • ACCESS Newswire • 05/04/2026 11:00:00 AM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2026 08:30:44 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 12:35:29 PM
- CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline • ACCESS Newswire • 03/11/2026 12:35:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 10:00:26 PM
- CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team • ACCESS Newswire • 03/02/2026 01:25:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2026 10:22:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 01:35:58 PM
- CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation • ACCESS Newswire • 02/17/2026 01:25:00 PM
- CNS Pharmaceuticals Issues Letter to Shareholders • ACCESS Newswire • 01/27/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 10:01:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 10:00:04 PM
- CNS Pharmaceuticals Shares Dip After CEO Departure Announcement • IH Market News • 12/17/2025 03:12:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2025 01:43:58 PM
- CNS Pharmaceuticals Announces CEO Transition • ACCESS Newswire • 12/17/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 10:19:16 PM
